Nicotine Lozenge
Product Images NDC 58602-854

4 FDA label images from Aurohealth Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nicotine (NDC 58602-854). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurohealth Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure1 (Nicotine Fig1)

Figure1 (Nicotine Fig1)
An instructional reminder diagram for nicotine polacrilex mini lozenge use, showing a calendar schedule with four circular steps. Step 1 recommends 1 lozenge every 1 to 2 hours at the beginning of week 1 (quit date). Step 2 is at week 7 for 1 lozenge every 2 to 4 hours. Step 3 at week 10 suggests 1 lozenge every 4 to 8 hours. The final circle labeled EX-SMOKER is placed 12 weeks after the quit date.*
FDA Label Image

Figure2 (Nicotine Fig2)

Figure2 (Nicotine Fig2)
An illustrated wallet card designed to support quitting smoking, featuring spaces to write personal reasons for quitting and contact information for support resources including the American Lung Association, American Cancer Society, American Heart Association, and suggestions to contact a quitting buddy or friend.*
FDA Label Image

Package Label.principal Display Panel (2 mg (27 Lozenges, Container Label))

Package Label.principal Display Panel (2 mg (27 Lozenges, Container Label))
The packaging label for NICOTINE POLACRILEX mini lozenge contains 2 mg strength per lozenge. It is a mint flavored, oral lozenge formulation provided by Aurohealth LLC. The label states it is a stop smoking aid, packaged with 27 lozenges, distributed by Aurohealth LLC in New Jersey, and made in India. Additional safety instructions advise retaining the outer carton, avoiding use if the tamper-evident seal is broken, and contacting Poison Control in case of overdose.*
FDA Label Image

Package Label.principal Display Panel (2 mg (27 Lozenges, Container Carton Label))

Package Label.principal Display Panel (2 mg (27 Lozenges, Container Carton Label))
The image shows packaging for Nicotine Polacrilex Lozenge 2 mg by Aurohealth LLC. It is an oral mint-flavored lozenge labeled as a stop smoking aid. The package contains 81 lozenges divided into 3 containers of 27 each. The label includes directions, warnings, ingredient information, and manufacturer details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.